Zobrazeno 1 - 10
of 3 078
pro vyhledávání: '"Meng Qiu"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Patients with BRAF 600E mutated mCRC are associated with specific clinicopathological features and poor prognosis. The relative efficacy of first-line FOLFOXIRI triplet chemotherapy or doublet chemotherapy combined with bevacizuma
Externí odkaz:
https://doaj.org/article/eb74d2392ccd43848b4a98e5e94b2487
Autor:
Atif Ahmed Siddiqui, Emmanuelle Merquiol, Reut Bruck-Haimson, Joud Hirbawi, Hana Boocholez, Irit Cohen, Yonghong Yan, Meng Qiu Dong, Galia Blum, Ehud Cohen
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract While the activities of certain proteases promote proteostasis and prevent neurodegeneration-associated phenotypes, the protease cathepsin B (CTSB) enhances proteotoxicity in Alzheimer’s disease (AD) model mice, and its levels are elevated
Externí odkaz:
https://doaj.org/article/e3c24ee5acc343fd87a60513d5ca45ab
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Immune checkpoint inhibitors (ICIs) have achieved remarkable success in clinical research and practice. Notably, liver metastasis is not sensitive to ICIs. Liver locoregional therapies can cause irreversible damage to tumor cells and release
Externí odkaz:
https://doaj.org/article/3669871c9af14f4b9bb4d3021b7eb4bd
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: Fruquintinib is a third-line and subsequent targeted therapy for patients with metastatic colorectal cancer (mCRC). Identifying survival predictors after fruquintinib is crucial for optimizing the clinical use of this medication. Objectiv
Externí odkaz:
https://doaj.org/article/529a581f9f254d13bb115aa02a344c22
Autor:
Tao Han, Meng Qiu, Xinxin Niu, Shumei wang, Feng Wang, Jingke Cao, Shanghong Tang, Liping Cheng, Yabo Mei, Huayu Liang, Zhichun Feng, Geyu Chen, Qiuping Li
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Invasive fungal infection (IFI) has become an increasing problem in NICU neonates, and end-organ damage (EOD) from IFI is one of the leading causes of morbidity and mortality in neonates. This study was conducted to summarize clin
Externí odkaz:
https://doaj.org/article/6c1e420f807f47aa8daa80a5c1924cd8
Autor:
Tao Han, Linhong Song, Xinxin Niu, Meng Qiu, Yi Wang, Jing Wang, Xiuyan Sun, Jiali Ma, Siqi Hu, Zhichun Feng
Publikováno v:
Heliyon, Vol 10, Iss 9, Pp e30489- (2024)
The SARS-CoV-2, responsible for the COVID-19 pandemic, poses a significant threat to global healthcare. Peptide and peptide-based inhibitors, known for their safety, efficacy, and selectivity, have recently emerged as promising candidates for treatin
Externí odkaz:
https://doaj.org/article/3fab603a22da47eab695b602dc8e3784
Publikováno v:
Heliyon, Vol 10, Iss 7, Pp e29249- (2024)
Peritoneal carcinomatosis (PC) is a type of secondary cancer which is not sensitive to conventional intravenous chemotherapy. Treatment strategies for PC are usually palliative rather than curative. Recently, artificial intelligence (AI) has been wid
Externí odkaz:
https://doaj.org/article/3a1b44785971420c8c09269fb38f6458
Publikováno v:
BMJ Open, Vol 13, Iss 12 (2023)
Objectives Carcinosarcoma (CS) is a rare and biphasic malignancy characterised by a highly invasive biological nature and poor prognosis. This study explored the epidemiology, site-specific characteristics and survival outcome of CS.Design We conduct
Externí odkaz:
https://doaj.org/article/313ab1d9b0ce49a196c26bb833b7afa5
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
For colorectal cancer (CRC), surgical resection remains essential for achieving good prognoses. Unfortunately, numerous patients with locally advanced CRC and metastatic CRC failed to meet surgical indications or achieve pathological complete respons
Externí odkaz:
https://doaj.org/article/48b24f1fe3a54c7c9013ae7c998f5ea3
Autor:
Li Tu, Weihan Zhang, Lu Ni, Zihan Xu, Kun Yang, Hongfeng Gou, Qing Zhu, Ming Liu, Yu Yang, Jiankun Hu, Meng Qiu
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 4161-4169 (2023)
Abstract Background Intraperitoneal paclitaxel is proved to be efficient for peritoneal metastasis of gastric cancer. It remains uncertain the efficacy and safety of the triplets regimen which combined intraperitoneal high‐dose paclitaxel with syst
Externí odkaz:
https://doaj.org/article/60fc5110660c4329958b4c87f17e5a67